This study is currently not recruiting participants.
Impact of a pharmacy-led drug-interaction screening program for patients receiving triple therapy for hepatitis C virus infection and assessment of adverse effects of triple therapy use in the general population
Not Recruiting
100 years or below
All
Phase
N/A
1 Location
Brief description of study.
The primary objective of this study is to determine the number and type of drug interactions identified in patients requiring treatment with telaprevir triple-therapy and characterize physician action based upon pharmacist recommendations. The secondary o
Detailed description of study
The primary objective of this study is to determine the number and type of drug interactions identified in patients requiring treatment with telaprevir triple-therapy and characterize physician action based upon pharmacist recommendations. The secondary o
Eligibility of study
You may be eligible for this study if you meet the following criteria:
Conditions:Hepatitis C
Age:
100 years or below
Gender: All
Updated on
05 Dec 2012.
Study ID: 1208009456
Interested in the study?
Select a study center that’s convenient for you, and get in touch with the study team.
